Jagdishwar Sahai Srivastava

Title: Jagdishwar Sahai Srivastava: Innovator in Malaria Treatment

Introduction

Jagdishwar Sahai Srivastava is a notable inventor based in Lucknow, India. He has made significant contributions to the field of medicine, particularly in the treatment of malaria. With a total of 2 patents to his name, his work has the potential to impact public health positively.

Latest Patents

His latest patents include a combination kit used in the treatment of malaria. This innovative kit comprises individual doses of an anti-malarial agent, specifically 3-[1-[[4-[(6-methoxy-8-quinolinyl)amino]pentyl]amino]ethylidene]-dihydro-2(3H)-furanone (I) in capsule form, and chloroquine in tablet form. The kit is designed for a six-day treatment regimen, where patients take five tablets containing 500 mg of chloroquine phosphate and five capsules containing 25 mg of the anti-malarial agent. Additionally, he has developed a novel use of a primaquine derivative, N-(3-ethylidinotetrahydrofuran-2-one)-N-(6-methoxy-8-quinolinyl)-1,4-pentanediamine, as a gametocytocidal agent for malaria treatment.

Career Highlights

Throughout his career, Jagdishwar has worked with esteemed organizations such as the Council of Scientific & Industrial Research and Nicholas Piramal India Limited. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.

Collaborations

He has collaborated with notable coworkers, including Ram Pratap and Amiya Prasad Bhaduri, to advance his research and innovations in malaria treatment.

Conclusion

Jagdishwar Sahai Srivastava's contributions to malaria treatment through his innovative patents highlight his dedication to improving public health. His work exemplifies the impact that inventors can have on addressing critical health challenges.